Early invasive cervical cancer: MRI and CT predictors of lymphatic metastases in the ACRIN 6651/GOG 183 intergroup study

Gynecologic Oncology

Volumn 112, Issue 1, 2009, Pages 95-103

  Mitchell, Donald G ^a   Snyder, Bradley ^b   Coakley, Fergus ^c   Reinhold, Caroline ^d,e   Thomas, Gillian ^f   Amendola, Marco A ^g   Schwartz, Lawrence H ^h   Woodward, Paula ⁱ   Pannu, Harpreet ^j   Atri, Mostafa ^k   Hricak, Hedvig ^h  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b BROWN UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e SYNARC INC   (United States)

^f DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^g VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

ⁱ UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^j JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

Cervical cancer; Computed tomography; FIGO; Imaging; Magnetic resonance imaging; Staging

Indexed keywords

ACCURACY; AREA UNDER THE CURVE; ARTICLE; CLINICAL EXAMINATION; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; EARLY CANCER; EARLY DIAGNOSIS; FEMALE; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MANTEL HAENSZEL TEST; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADICAL HYSTERECTOMY; RADIOLOGIST; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; STATISTICS; TUMOR VOLUME; UNIVARIATE ANALYSIS; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER;

FEMALE; HUMANS; HYSTERECTOMY; LOGISTIC MODELS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MAGNETIC RESONANCE IMAGING; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; OBSERVER VARIATION; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 57649128506     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.10.005     Document Type: Article

References (35)

1. Sironi S., Buda A., Picchio M., Perego P., Moreni R., Pellegrino A., et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology 238 1 (2006) 272-279 [Jan]
2. Zreik T.G., Chambers J.T., and Chambers S.K. Parametrial involvement, regardless of nodal status: a poor prognostic factor for cervical cancer. Obstet. Gynecol. 87 5 Pt 1 (1996) 741-746 [May]
3. Kosary C.L. FIGO stage, histology, histologic grade, age and race as prognostic factors in determining survival for cancers of the female gynecological system: an analysis of 1973-87 SEER cases of cancers of the endometrium, cervix, ovary, vulva, and vagina. Semin. Surg. Oncol. 10 1 (1994) 31-46
4. Chung C.K., Nahhas W.A., Stryker J.A., Curry S.L., Abt A.B., and Mortel R. Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix. Am. J. Obstet. Gynecol. 138 5 (1980) 550-556 [Nov]
5. Carl U.M., Bahnsen J., and Wiegel T. Radiation therapy of para-aortic lymph nodes in cancer of the uterine cervix. Acta Oncol. 32 1 (1993) 63-67
6. Tsai C.S., Lai C.H., Wang C.C., Chang J.T., Chang T.C., Tseng C.J., et al. The prognostic factors for patients with early cervical cancer treated by radical hysterectomy and postoperative radiotherapy. Gynecol. Oncol. 75 3 (1999) 328-333 [Dec]
7. Huang H.J., Chang T.C., Hong J.H., Tseng C.J., Chou H.H., Huang K.G., et al. Prognostic value of age and histologic type in neoadjuvant chemotherapy plus radical surgery for bulky (> / = 4 cm) stage IB and IIA cervical carcinoma. Int. J. Gynecol. Cancer. 13 2 (2003) 204-211
8. Kodaira T., Fuwa N., Toita T., Nomoto Y., Kuzuya K., Tachibana H., et al. Comparison of prognostic value of MRI and FIGO stage among patients with cervical carcinoma treated with radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 56 3 (2003) 769-777 [Jul]
9. Kim P.Y., Monk B.J., Chabra S., Burger R.A., Vasilev S.A., Manetta A., et al. Cervical cancer with paraaortic metastases: significance of residual paraaortic disease after surgical staging. Gynecol. Oncol. 69 3 (1998) 243-247 [Jun]
10. Hong J., Lai C., Tsai C., Chang T., Wang C., and Chou H. Recurrent squamous cell carcinoma of cervix after primary radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 57 2 Suppl (2003) S344-S345 [Oct]
11. Keys H.M., Bundy B.N., Stehman F.B., Okagaki T., Gallup D.G., Burnett A.F., et al. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol. Oncol. 89 3 (2003) 343-353 [Jun]
12. Mayr N.A., Taoka T., Yuh W.T., Denning L.M., Zhen W.K., Paulino A.C., et al. Method and timing of tumor volume measurement for outcome prediction in cervical cancer using magnetic resonance imaging. Int. J. Radiat. Oncol. Biol. Phys. 52 1 (2002) 14-22 [Jan]
13. Narayan K, McKenzie AF, Hicks RJ, Fisher R, Bernshaw D, Bau D. Relation between FIGO stage, primary tumor volume, and presence of lymph node metastases in cervical cancer patients referred for radiotherapy. 2003;13(5):657-63.
14. Montana G.S., Hanlon A.L., Brickner T.J., Owen J.B., Hanks G.E., Ling C.C., et al. Carcinoma of the cervix: patterns of care studies: review of 1978, 1983, and 1988-1989 surveys. Int. J. Radiat. Oncol. Biol. Phys. 32 5 (1995) 1481-1486 [Jul]
15. Chung H., Ahn H.S., Kim Y.S., Lee E.J., Ryu H.S., Chang K.H., et al. The value of cystoscopy and intravenous urography after magnetic resonance imaging or computed tomography in the staging of cervical carcinoma. Yonsei Med. J. 42 5 (2001) 527-531 [Oct]
16. Follen M., Levenback C.F., Iyer R.B., Grigsby P.W., Boss E.A., Delpassand E.S., et al. Imaging in cervical cancer. Cancer 98 9 Suppl (2003) 2028-2038 [Nov]
17. Amendola M.A., Hricak H., Mitchell D.G., Snyder B., Chi D.S., Long III H.J., et al. Utilization of diagnostic studies in the pretreatment evaluation of invasive cervical cancer in the United States: results of intergroup protocol ACRIN 6651/GOG 183. J. Clin. Oncol. 23 30 (2005) 7454-7459 [Oct 20]
18. Hricak H., Gatsonis C., Chi D.S., Amendola M.A., Brandt K., Schwartz L.H., et al. Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study ACRIN 6651-GOG 183. J. Clin. Oncol. 23 36 (2005) 9329-9337 [Dec 20]
19. Mitchell D.G., Snyder B., Coakley F., Reinhold C., Thomas G., Amendola M., et al. Early invasive cervical cancer: tumor delineation by magnetic resonance imaging, computed tomography, and clinical examination, verified by pathologic results, in the ACRIN 6651/GOG 183 Intergroup Study. J. Clin. Oncol. 24 36 (2006) 5687-5694 [Dec 20]
20. Hricak H., Gatsonis C., Coakley F.V., Snyder B., Reinhold C., Schwartz L.H., et al. Early invasive cervical cancer: CT and MR imaging in preoperative evaluation - ACRIN/GOG comparative study of diagnostic performance and interobserver variability. Radiology. 245 2 (2007) 491-498 [Nov]
21. Ballon S.C., Berman M.L., Lagasse L.D., Petrilli E.S., and Castaldo T.W. Survival after extraperitoneal pelvic and paraaortic lymphadenectomy and radiation therapy in cervical carcinoma. Obstet. Gynecol. 57 1 (1981) 90-95 [Jan]
22. Bleker O.P., Ketting B.W., van_Wayjen_Eecen B., and Kloosterman G.J. The significance of microscopic involvement of the parametrium and/or pelvic lymph nodes in cervical cancer stages IB and IIA. Gynecol. Oncol. 16 1 (1983) 56-62 [Aug]
23. LaPolla J.P., Schlaerth J.B., Gaddis O., and Morrow C.P. The influence of surgical staging on the evaluation and treatment of patients with cervical carcinoma. Gynecol. Oncol. 24 2 (1986) 194-206 [Jun]
24. Delgado G., Bundy B., Zaino R., Sevin B.U., Creasman W.T., and Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study. Gynecol. Oncol. 38 3 (1990) 352-357 [Sep]
25. Alvarez R.D., Potter M.E., Soong S.J., Gay F.L., Hatch K.D., Partridge E.E., et al. Rationale for using pathologic tumor dimensions and nodal status to subclassify surgically treated stage IB cervical cancer patients. Gynecol. Oncol. 43 2 (1991) 108-112 [Nov]
26. Kataoka M., Kawamura M., Nishiyama Y., Hamamoto K., Hamada K., Iketani H., et al. Patterns of failure and survival in locally advanced carcinoma of the uterine cervix treated with high dose-rate intracavitary irradiation system. Int. J. Radiat. Oncol. Biol. Phys. 22 1 (1992) 31-35
27. Landoni F., Maneo A., Colombo A., Placa F., Milani R., Perego P., et al. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet 350 9077 (1997) 535-540 [1997/8/23]
28. Hong J.H., Tsai C.S., Lai C.H., Chang T.C., Wang C.C., Lee S.P., et al. Postoperative low-pelvic irradiation for stage I-IIA cervical cancer patients with risk factors other than pelvic lymph node metastasis. Int. J. Radiat. Oncol. Biol. Phys. 53 5 (2002) 1284-1290 [Aug]
29. Trattner M., Graf A.H., Lax S., Forstner R., Dandachi N., Haas J., et al. Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol. Oncol. 82 1 (2001) 11-16 [Jul]
30. Chou H.H., Wang C.C., Lai C.H., Hong J.H., Ng K.K., Chang T.C., et al. Isolated paraaortic lymph node recurrence after definitive irradiation for cervical carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 51 2 (2001) 442-448 [Oct]
31. Wang C.J., Lai C.H., Huang H.J., Hong J.H., Chou H.H., Huang K.G., et al. Recurrent cervical carcinoma after primary radical surgery. Am. J. Obstet. Gynecol. 181 3 (1999) 518-524 [Sep]
32. Lai C.H., Hong J.H., Hsueh S., Ng K.K., Chang T.C., Tseng C.J., et al. Preoperative prognostic variables and the impact of postoperative adjuvant therapy on the outcomes of Stage IB or II cervical carcinoma patients with or without pelvic lymph node metastases: an analysis of 891 cases. Cancer 85 7 (1999) 1537-1546 [Apr]
33. Fleiss J., Levin B., and Paik M. Statistical methods for rates and proportions. 3rd ed. (2003), Wiley-Interscience, Hoboken, NJ
34. Pepe M.S., Janes H., Longton G., Leisenring W., and Newcomb P. Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker. Am. J. Epidemiol. 159 9 (2004) 882-890 [May 1]
35. DeLong E.R., DeLong D.M., and Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44 3 (1988) 837-845 [Sep]